Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a in children with chronic hepatitis B
ChiCTR-OPC-17013085Phase 4Suspended
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Combined response rate. Started Oct 2017; status: suspended.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPC-17013085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013085.